Treatment of alcohol withdrawal
110 results
1 - 100
Treatment of alcohol withdrawal 
Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Benzodiazepines for alcohol withdrawal
- Neurological disorders and alcohol
- Anticonvulsants for alcohol withdrawal
- Benzodiazepines for alcohol withdrawal
Nalmefene may not be effective for alcohol withdrawal- Magnesium for alcohol withdrawal: Cochrane systematic review
- Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
- Baclofen for alcohol withdrawal
- Treatment of drug addicts
- Providing care for an alcohol or drug abuser
- Dual diagnosis
- Pharmacotherapy for anxiety and comorbid alcohol use disorders
- Benzodiazepines for delirium
- Naltrexone for smoking withdrawal
- A patient with legal drug addiction in primary care
- Magnesium and alcohol withdrawal syndrome
- Nalmefene for alcohol dependence
- Long-term benzodiazepine use and withdrawal
- Home visits during pregnancy and after birth for women with an alcohol or drug problem
- Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol
- Anticonvulsants for alcohol dependence: Cochrane systematic review
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- aDrugs commonly causing poisonings
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence: Cochrane systematic review
- Perioperative alcohol cessation intervention for postoperative complications
- Gabapentin increases short-term alcohol abstinence in motivated patients
- Drugs used in alcohol dependence
- Antidepressants for co-occurring depression and alcohol dependence
- Delirium in the elderly
- Encountering a violent or threatening patient
- Alpha 2 -adrenergic agonists for the management of opioid withdrawal: Cochrane systematic review
- Pregnant substance abuser
- Alcohol poisoning
- Music therapy for people with substance use disorders
- Acute psychosis
- Eszopiclone for insomnia: Cochrane systematic review
- Oral topiramate for alcohol dependence
- Naltrexone for alcohol dependence
- Anxiety disorder
- Treatment of dyslipidaemias
- Mental disorders due to somatic disease
- Acupuncture
- Episodic symptoms associated with sleep
- Interventions for preventing infectious complications in haemodialysis patients with central venous catheters
- Benzodiazepines for schizophrenia: Cochrane systematic review
- Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit
- Acute stress reaction and post-traumatic stress disorder
- Lifestyle changes for treating psoriasis
- Intra-articular glucocorticoids for acute gout: Cochrane systematic review
- Treatment of poisoning
- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
- Oral CBD promising for treatment of heroin use disorder
- Lifestyle interventions for chronic gout
- Slow-release oral morphine as maintenance therapy for opioid dependence: Cochrane systematic review
- Quetiapine + haloperidol = faster resolution of ICU delirium
- Adolescent substance abuse
- Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
- Plugs for containing faecal incontinence
- Interventions for tophi in gout
- Urinary incontinence in the elderly